Literature DB >> 32118727

Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study.

Li Yin1, Delong Zhang2, Qian Ren1, Xian Su1, Zhaohui Sun1.   

Abstract

In China, there is a significant lack of awareness of diabetes and its complications. Screening of diabetic retinopathy has important for early detection, prevention, and treatment. This large, cross-sectional study aimed to characterize the demographic, physical, serological, and ocular characteristics of subjects with diabetes mellitus in Shijiazhuang, China. It also aimed to associate these characteristics with the presence of diabetic retinopathy.From May 2, 2018 to August 25, 2019, under diabetes care program, the diabetic patients (n = 1008) were subjected to standardized questionnaires to collect demographical characteristics. Also, telescreens and laboratory tests were performed for the enrolled patients. Multivariate logistic regression analysis was used to evaluate factors associated with diabetic retinopathy.Forty percent of diabetics in its population had some form of diabetic retinopathy. Diabetic retinopathic patients were likely to be elder (P = .0003), men (P = .018), hypertensive (P < .0001), and had high body mass index (P < .0001), metabolic abnormalities, and longer duration of diabetes (P < .0001). Higher intraocular pressure (P = .0008), fasting blood glucose (P < .0001), serum total cholesterol (P < .0001), serum triglyceride (P = .0006), % glycated hemoglobin (HbA1c) (P < .0001), and disc asymmetry including cup-disc ratio (P = .041) reported in patients with diabetic retinopathy. Age (P = .049), male sex (P = .048), hypertension (P = .048), duration of diabetes (P = .012), diabetic neuropathy (P = .048), diabetic nephropathy (P = .048), diabetic foot ulcer (P = .041), foot amputation (P = .042), fasting blood glucose (P = .022), serum total cholesterol (P = .028), serum triglyceride (P = .035), and HbA1c (P = .042) were associated with diabetic retinopathy.Diabetic retinopathy was the most common ocular fundus disease in diabetic patients. Also, aging, the other comorbidities, and metabolic syndrome are associated with diabetic retinopathy.Level of Evidence: III.

Entities:  

Year:  2020        PMID: 32118727     DOI: 10.1097/MD.0000000000019236

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  17 in total

1.  Prevalence and risk factors of chronic complications among patients with type 2 diabetes mellitus in Morocco: a cross-sectional study.

Authors:  Houda El Alami; Imane Haddou; Ghizlane Benaadi; Mustapha Lkhider; Driss El Habchi; Lahcen Wakrim; Naima Nabih; Omar Abidi; Naima Khlil; Abderrahmane Maaroufi; Abderrahim Naamane; Salsabil Hamdi
Journal:  Pan Afr Med J       Date:  2022-03-08

2.  Biscuit consumption and diabetic retinopathy incidence in adults in the United States.

Authors:  Ke Shi; Yuhong Chen; Xinyue Zhu; Jiali Wu; Jieqiong Chen; Jing Hu; Xiaodong Sun; Jingfa Zhang
Journal:  Diabetol Metab Syndr       Date:  2022-07-06       Impact factor: 5.395

3.  Nomogram-Based Prediction of the Risk of Diabetic Retinopathy: A Retrospective Study.

Authors:  Ruohui Mo; Rong Shi; Yuhong Hu; Fan Hu
Journal:  J Diabetes Res       Date:  2020-06-07       Impact factor: 4.011

4.  Clinical and Molecular-Genetic Insights into the Role of Oxidative Stress in Diabetic Retinopathy: Antioxidant Strategies and Future Avenues.

Authors:  Silvia M Sanz-González; José J García-Medina; Vicente Zanón-Moreno; María I López-Gálvez; David Galarreta-Mira; Lilianne Duarte; Mar Valero-Velló; Ana I Ramírez; J Fernando Arévalo; María D Pinazo-Durán
Journal:  Antioxidants (Basel)       Date:  2020-11-09

5.  Association between PPAR-γ2 gene polymorphisms and diabetic retinopathy risk: a meta-analysis.

Authors:  Xue-Feng Li; Guang-Bin Jiang; Shi-Yan Cheng; Ya-Feng Song; Cai Deng; Yu-Ming Niu; Jun-Wei Cai
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

6.  Protective Effects of Fucoxanthin on High Glucose- and 4-Hydroxynonenal (4-HNE)-Induced Injury in Human Retinal Pigment Epithelial Cells.

Authors:  Yi-Fen Chiang; Hsin-Yuan Chen; Yen-Jui Chang; Yin-Hwa Shih; Tzong-Ming Shieh; Kai-Lee Wang; Shih-Min Hsia
Journal:  Antioxidants (Basel)       Date:  2020-11-25

7.  Prevalence and Risk Factors of Sensory Symptoms in Diabetes Patients in Taiwan.

Authors:  Chin-Hsiao Tseng; Choon-Khim Chong; Jau-Jiuan Sheu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

8.  Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review.

Authors:  Panagiotis Dervenis; Nikolaos Dervenis; David Steel; Teresa Sandinha; Paris Tranos; Panagiotis Vasilakis; Ioannis Liampas; Chrysoula Doxani; Elias Zintzaras
Journal:  Ther Adv Ophthalmol       Date:  2021-12-06

9.  Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy.

Authors:  Chi-Juei Jeng; Yi-Ting Hsieh; Cheng-Li Lin; I-Jong Wang
Journal:  BMC Ophthalmol       Date:  2022-03-17       Impact factor: 2.209

10.  Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA.

Authors:  Teer Ba; Lili Zhou; Han Zhang; Xiaoguang Zhang; Shixuan Guo; Huixia Li; Haiyan Tian; Qiqige Caihan; Gang Bai; Jing Zhou; Lao Qi; Xueyan Zhang; Guisen Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.